Cargando...

Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis

BACKGROUND: The current Canadian and US guidelines for the treatment of multidrug-resistant latent tuberculosis infection advocate the use of pyrazinamide and a fluoroquinolone as a first-line treatment option. However, there is very little information in the literature that describes the use of the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Papastavros, Tina, Dolovich, Lisa R., Holbrook, Anne, Whitehead, Lori, Loeb, Mark
Formato: Artigo
Lenguaje:Inglês
Publicado: 2002
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC117089/
https://ncbi.nlm.nih.gov/pubmed/12160118
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!